MAIA BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.75 USD | +8.20% |
|
+27.01% | +305.98% |
| 05-21 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
| 05-14 | MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 38.42 | 19.82 | 103.7 | - |
| Enterprise Value (EV) 1 | 38.42 | 19.82 | 103.7 | 103.7 |
| P/E ratio | -2.01 x | -0.79 x | -3 x | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | - | 2.93 x |
| EV / Revenue | - | - | - | 2.93 x |
| EV / EBITDA | -2.38 x | -0.98 x | -3.52 x | -2.93 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 10,946 | 16,944 | 21,837 | - |
| Reference price 2 | 3.510 | 1.170 | 4.750 | 4.750 |
| Announcement Date | 23-03-24 | 24-03-21 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | 35.39 |
| EBITDA 1 | - | -16.18 | -20.18 | -29.48 | -35.39 |
| EBIT 1 | - | -16.18 | -20.18 | -33.48 | -34.54 |
| Operating Margin | - | - | - | - | -97.62% |
| Earnings before Tax (EBT) 1 | - | -15.77 | -19.77 | -33.49 | -34.55 |
| Net income 1 | -12.5 | -16.22 | -19.77 | -33.49 | -34.55 |
| Net margin | - | - | - | - | -97.64% |
| EPS 2 | -2.370 | -1.750 | -1.490 | -1.585 | - |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 22-04-11 | 23-03-24 | 24-03-21 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT | - | -5.294 | -4.184 | -4.665 | -4.956 | -6.378 | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | -5.117 | -4.117 | -4.524 | -4.876 | -6.257 | - | - | - | - |
| Net income | - | -5.568 | -4.117 | -4.524 | -4.876 | -6.257 | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -0.4800 | -0.3500 | -0.3800 | -0.3500 | -0.3600 | -0.4100 | -0.4600 | -0.4150 | -0.3950 | -0.3850 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 23-02-06 | 23-03-24 | 23-05-08 | 23-08-08 | 23-11-07 | 24-03-21 | 24-05-14 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 22-04-11 | 23-03-24 | 24-03-21 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.75
USD
Average target price
12.62
USD
Spread / Average Target
+165.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +305.98% | 104M | |
| +43.36% | 54.63B | |
| -5.31% | 39.92B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B | |
| -11.83% | 10.74B |
- Stock Market
- Equities
- MAIA Stock
- Financials MAIA Biotechnology, Inc.
